The Association between Adverse Pregnancy Outcomes and Laboratory Measures as Risk for Cardiovascular Disorders


  • Haneen Hussein Farhood Clinical Pharmacy department/ College of Pharmacy/ Mustansiriyah University
  • Manal Khalid Abdulridha Department of Clinical Pharmacy/College of Pharmacy/ Mustansiriyah University
  • Hameedah Hadi Consultant Gynecologist/Karbala Holy Health Directorate



; Adverse Pregnancy Outcomes, Cardiovascular Disease, Framingham Risk Score.


Background; Due to the complicated etiology of cardiovascular illnesses, a thorough risk assessment is necessary for screening reasons. Many published studies relate the pregnancy complications and future cardiovascular disease (CVD) risk. Objective; Investigate the association between risk factors of the laboratory measures and adverse pregnancy outcomes (APOs) with level of cardiovascular disorders risk. Methods; Adult women were enrolled in a cross-sectional study, and they were divided into 2 groups according to whether they had a history of adverse pregnancy outcomes or not. Laboratory and clinical measurements were carried out, and The CVD risk was calculated according to Framingham risk score. Results; All women enrolled were over 40 years age, mostly obese, had predominantly A+ve and O+ve blood group phenotypes. As compared to the low risk category, women with a positive history of pregnancy-induced hypertension and preeclampsia were 7.5 times more likely to be in the intermediate group while those with a positive history of stillbirth were 17.2 times more likely to be in the high-risk group. Conclusion; With reference to the low risk category, a positive history of pregnancy-induced hypertension and preeclampsia was predictor for intermediate CVD risk, while a positive history of stillbirth was predictor for high CVD risk.


cardiovascular disease. Nat Rev Cardiol. 2015;12(11):627–42. DOI:

Bansilal S, Castellano JM, Fuster V. Global burden of CVD: Focus on secondary prevention of cardiovascular disease. Int J Cardiol 2015;201:S1–7. DOI:

Kumar Khanal M, Ahmed AM, Moniruzzaman M, Chandra Banik P, Dhungana R, Bhandari P, et al. Total cardiovascular risk for next 10 years among rural population of Nepal using WHO/ ISH risk prediction chart. BMC Res Notes 2017;10:120. DOI:

Brown HL, Smith GN. Pregnancy Complications, Cardiovascular Risk Factors, and Future Heart Disease. Obstet Gynecol Clin North Am. 2020;47(3):487–95. DOI:

Bansal P, Chaudhary A, Wander P, Satija M, Sharma S, Girdhar S, et al. Cardiovascular Risk Assessment Using WHO/ISH Risk Prediction Charts In a Rural Area of North India. J Res Med Dent Sci 2016;4(2):127. DOI:

Wang J, Tan GJ, Han LN, Bai YY, He M, Liu HB. Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol 2017;14:135–50.

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019. J Am Coll Cardiol. 2020;76(25):2982–3021. DOI:

Cardiovascular diseases. [cited 2022 May 28];Available from:

Groenewegen KA, Den Ruijter HM, Pasterkamp G, Polak JF, Bots ML, Peters SAE. Vascular age to determine cardiovascular disease risk: A systematic review of its concepts, definitions, and clinical applications. Eur. J. Prev. Cardiol.2016;23(3):264–74. DOI:

Jahangiry L, Farhangi MA, Rezaei F. Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome. J Heal Popul Nutr 2017;36(1):36.

Parikh NI, Gonzalez JM, Anderson CAM, Judd SE, Rexrode KM, Hlatky MA, et al. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circulation 2021;143(18):E902–16. DOI:

Park K, Minissian MB, Wei J, Saade GR, Smith GN. Contemporary clinical updates on the prevention of future cardiovascular disease in women who experience adverse pregnancy outcomes. Clin Cardiol 2020;43(6):553–9. DOI:

Wu P, Mamas MA, Gulati M. Pregnancy As a Predictor of Maternal Cardiovascular Disease: The Era of CardioObstetrics. J Women’s Heal 2019;28(8):1037–50. DOI:

Sharma G, Zakaria S, Michos ED, Bhatt AB, Lundberg GP, Florio KL, et al. Improving Cardiovascular Workforce Competencies in Cardio‐Obstetrics: Current Challenges and Future Directions. J Am Heart Assoc 2020;9(12):15569. DOI:

World Medical Association. Ethical Principles for Medical Research Involving Human Subjects. Eur J Emerg Med 2001;8(3):221–3. DOI:

Abdulaali AR, Abdulridha MK, Sameh I, Al-turfi HH. Effect of Vitamin D3 Supplement on Biochemical Markers and Blood Pressure Reading in Hypertensive patients as A secondary Prevention. Al Mustansiriyah J Pharm Sci 2018;18(2):24–32. DOI:

Clinical Biochemistry / Lipids - SPINREACT. [cited 2022 Jun 13];Available from:

Rodondi N, Locatelli I, Aujesky D, Butler J, Vittinghoff E, Simonsick E, et al. Framingham Risk Score and Alternatives for Prediction of Coronary Heart Disease in Older Adults. PLoS One 2012;7(3):e34287. DOI:

Jahangiry L, Farhangi MA, Rezaei F. Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome. J Heal Popul Nutr 2017;36(1):1–6. DOI:

Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, et al. Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications. Circulation. 2019;139(8):1069–79. DOI:

Niran Kamel* WM, Wasan Munim, Alaa Raheem Kareem, Mustafa Rasool Hussein Aal-Saleh, Mohammed Luay Subhi, Sarah Abdulkareem Ali Al-Dujaili. Lipid Profile Changes in Pregnant Women with Pre-Eclampsia and Their Correlation with Severety of Pre-Eclampsia. Al Mustansiriyah J Pharm Sci 2020;20(3):105–13. DOI:

Minhas AS, Ying W, Ogunwole SM, Miller M, Zakaria S, Vaught AJ, et al. The Association of Adverse Pregnancy Outcomes and Cardiovascular Disease: Current Knowledge and Future Directions. Curr Treat Options Cardiovasc Med 2020;22(12):61. DOI:

Stuart JJ, Tanz LJ, Cook NR, Spiegelman D, Missmer SA, Rimm EB, et al. Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction. J Am Coll Cardiol 2018;72(11):1252–63. DOI:

Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia Is Associated With Persistent Postpartum Cardiovascular Impairment. Hypertension. 2011;58(4):709–15. DOI:

Markovitz AR, Stuart JJ, Horn J, Williams PL, Rimm EB, Missmer SA, et al. Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway. Eur Heart J. 2019;40(14):1113–20. DOI:

Athukorala C, Rumbold AR, Willson KJ, Crowther CA. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy Childbirth 2010;10(1):56. DOI:

Phaloprakarn C, Tangjitgamol S. Maternal ABO blood group and adverse pregnancy outcomes. J Perinatol 2013 332 2012;33(2):107–11. DOI:

Aghasadeghi F, Saadat M. Association between ABO and Rh blood groups and risk of preeclampsia: A case-control study from Iran. Open Access Maced J Med Sci 2017;5(2):173–6. DOI:

Moazzeni SS, Toreyhi H, Asgari S, Azizi F, Tehrani FR, Hadaegh F. Number of parity/live birth(s) and cardiovascular disease among Iranian women and men: results of over 15 years of follow-up. BMC Pregnancy Childbirth. 2021;21(1):28. DOI:

Ogunmoroti O, Osibogun O, Kolade OB, Ying W, Sharma G, Vaidya D, et al. Multiparity is associated with poorer cardiovascular health among women from the Multi-Ethnic Study of Atherosclerosis. Am J Obstet Gynecol 2019;221(6):631.e1-631.e16. DOI:

Dallak FH, Gosadi IM, Haidar WN, Durayb AA, Alomaish AR, Alshamakhi AH, et al. Prevalence of adverse birth outcomes and associated factors in Jazan, Saudi Arabia: A cross-sectional study. Medicine (Baltimore) 2022;101(41):e31119. DOI:

Alfadhli EM, Osman EN, Basri TH, Mansuri NS, Youssef MH, Assaaedi SA, et al. Gestational diabetes among Saudi women: prevalence, risk factors and pregnancy outcomes. Ann Saudi Med. 2015;35(3):222–30. DOI:

Groof Z, Garashi G, Husain H, Owayed S, AlBader S, Mouhsen H, et al. Prevalence, Risk Factors, and Fetomaternal Outcomes of Gestational Diabetes Mellitus in Kuwait: A Cross-Sectional Study. J Diabetes Res. 2019;2019:1–7. DOI:

Subki AH, Algethami MR, Baabdullah WM, Alnefaie MN, Alzanbagi MA, Alsolami RM, et al. Prevalence, Risk Factors, and Fetal and Maternal Outcomes of Hypertensive Disorders of Pregnancy: A Retrospective Study in Western Saudi Arabia. Oman Med J. 2018;33(5):409–15. DOI:

Selvarajah S, Kaur G, Haniff J, Cheong KC, Hiong TG, van der Graaf Y, et al. Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population. Int J Cardiol 2014;176(1):211–8. DOI:

Bansal M, Kasliwal RR, Trehan N. Relationship between different cardiovascular risk scores and measures of subclinical atherosclerosis in an Indian population. Indian Heart J 2015;67(4):332–40. DOI:

Bansal M, Kasliwal RR, Trehan N. Comparative accuracy of different risk scores in assessing cardiovascular risk in Indians: A study in patients with first myocardial infarction. Indian Heart J 2014;66(6):580–6. DOI:

Garg N, Muduli SK, Kapoor A, Tewari S, Kumar S, Khanna R, et al. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses. Indian Heart J. 2017;69(4):458–63. DOI:

Takahashi MM, de Oliveira EP, de Carvalho ALR, de Souza Dantas LA, Burini FHP, Portero-McLellan KC, et al. Metabolic syndrome and dietary components are associated with coronary artery disease risk score in free-living adults: a cross-sectional study. Diabetol Metab Syndr 2011;3(1):7. DOI:

Groenhof TKJ, Zoet GA, Franx A, Gansevoort RT, Bots ML, Groen H, et al. Trajectory of Cardiovascular Risk Factors After Hypertensive Disorders of Pregnancy. Hypertension. 2019;73(1):171–8. DOI:

Mito A, Arata N, Qiu D, Sakamoto N, Murashima A, Ichihara A, et al. Hypertensive disorders of pregnancy: a strong risk factor for subsequent hypertension 5 years after delivery. Hypertens Res. 2018;41(2):141–6. DOI:

Garre I, Nemani L, Nallagasu R. Association of Pregnancy-Related Factors and Cardiovascular Disease in the Long Term. Indian J Cardiovasc Dis Women WINCARS. 2018;03(02/03):184–8. DOI:

Asgharvahedi F, Gholizadeh L, Siabani S. The risk of cardiovascular disease in women with a history of miscarriage and/or stillbirth. Health Care Women Int 2019;40(10):1117–31. DOI:




How to Cite

Haneen Hussein Farhood, Manal Khalid Abdulridha, & Hameedah Hadi. (2023). The Association between Adverse Pregnancy Outcomes and Laboratory Measures as Risk for Cardiovascular Disorders . Al Mustansiriyah Journal of Pharmaceutical Sciences, 23(2), 127–139.